BPC-157 lowers pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-) and Interleukin-6 (IL-6), reducing immune-driven tissue damage, while activating epithelial and fibroblast cells to regenerate the mucosal lining
Swisher SG , Anderson TM, Wen DR, Stene MA, Cochran AJ, Golub SH, Holmes EC
The poly (2-ethyl-2oxazoline) polymer compound of rotigotine for Parkinsons disease is presently in Phase 1 of a clinical investigation funded by Serina Therapeutics ( NCT02579473 )
El-Saiy KA, Sayed RH, El-Sahar AE, Kandil EA (2022) Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson's disease model in rats
Skincare trends Searches for moxi laser and nano needling reveal that consumers are seeking out in-office procedures even if they are pricier than at-home solutions
Muscle fullness improves for those combining CJC-1295 with resistance training
